Genotype Combination of rs1042044 and rs6458093 in GLP-1R as A Genetic Risk for Osteoporosis in Postmenopausal Iraqi Women
Abstract
BACKGROUND: Many genetic factors are known to be related to osteoporosis, and currently the role of the glucagon-like peptide-1 receptor (GLP-1R) gene in bone health has been studied intensively. Some variation of this gene, such as rs1042044 and rs6458093, are known to be linked to metabolic diseases and lower bone mineral density, however their specific contribution to osteoporosis remains largely unexplored. Therefore, this study was conducted to investigate the combined genotypic effect of rs1042044 and rs6458093 as a genetic risk factor for osteoporosis in postmenopausal Iraqi women.
METHODS: Blood samples from 75 osteoporosis patients and 75 healthy controls, aged 45-85, were collected. DNA was extracted, and a region of GLP-1R gene was amplified by polymerase chain reaction (PCR) and sequenced using the Sanger method to identify polymorphisms. Serum parathyroid hormone (PTH) levels were also measured with chemiluminescent immunoassay (CLIA) methods.
RESULTS: Significant differences were observed for age, menopausal age, and PTH levels (p<0.001), but not for Body Mass Index (BMI). While individual SNPs (rs1042044 and rs6458093) showed no significant association with osteoporosis, a specific genotype combination of rs1042044 A and rs6458093 G was found to be a highly significant risk factor for the disease (OR=21.85, p=0.026). Linkage Disequilibrium analysis showed a D' value=0.85 and R²=0.45 between the two SNPs.
CONCLUSION: Co-occurrence of the 'A' allele at rs1042044 and the 'G' allele at rs6458093 creates a highly susceptible genetic risk factor for osteoporosis, highlighting a potential novel biomarker for disease risk and providing a benchmark for future studies.
KEYWORDS: osteoporosis, postmenopausal, GLP1R, PTH, SNPS
Full Text:
PDFReferences
Al-Barazenji T, Allouch A, Al Husaini N, Yousef S, Ibrahim WN, Al-Haidose A, et al. Association between vitamin D receptor BsmI polymorphism and low bone mineral density in postmenopausal women in the MENA region. Pathophysiology. 2025; 32(1): 6, CrossRef.
Johnston CB, Dagar M. Osteoporosis in older adults. Med Clin North Am. 2020; 104(5): 873-84, CrossRef.
Shamsulddin HH, Salih LA, Eleiwe SA. Relationship between osteopontin biochemical parameters and BMD status in Iraqi postmenopausal women with osteoporosis. Iraqi J Sci. 2020: 61(10): 2494-503, CrossRef.
Hameed ZA, Radhi NJ. The impact of osteoporosis on teeth decay in relation to salivary vitamin D among menopause in Baghdad city, Iraq. Al-Kindy Coll Med J. 2023; 19(2): 163-7, CrossRef.
Ikawati M, Ertanto Y, Endah ES, Pudjiraharti S, Meiyanto E, Jenie RI. Anti-osteoporosis potencies of Zingiber officinale Rosc. Rhizome water extract and DFA III produced from Dahlia Spp. L.: In vivo and in vitro studies. Indones Biomed J. 2022; 14(1): 104-15, CrossRef.
Jusup I, Batubara L, Ngestiningsih D, Fulyani F, Paveta DA, Bancin PTLA. Association between malondialdehyde, GSH/GSSG ratio and bone mineral density in postmenopausal women. Mol Cell Biomed Sci. 2021; 5(1): 13-7, CrossRef.
Lu L, Tian LJJoE. Postmenopausal osteoporosis coexisting with sarcopenia: the role and mechanisms of estrogen. 2023; 259(1): e230116, CrossRef.
Jameel MG, Alhakeem ZM, Al-Osami MH. Prevalence of AGER gene polymorphism in post menopause Iraqi sample with Osteoporosis and osteopenia in type 2DM. Iraqi J Pharm Sci. 2022; 31(2): 202-10, CrossRef.
Wu Q, Jung J. Genome-wide polygenic risk score for major osteoporotic fractures in postmenopausal women using associated single nucleotide polymorphisms. J Transl Med. 2023; 21(1): 127, CrossRef.
Noh JY, Yang Y, Jung H. Molecular mechanisms and emerging therapeutics for osteoporosis. Int J Mol Sci. 2020; 21(20): 7623, CrossRef.
Tabor E, Górczyńska-Kosiorz S, Pluskiewicz W, Gumprecht J. Bone fracture incidence in postmenopausal women: Results of a 10 year follow up in a RAC-OST-POL study of rs1544410, rs7975232 and rs731236 polymorphisms. Nutrients. 2024; 16(23): 4146, CrossRef.
Górczyńska-Kosiorz S, Tabor E, Niemiec P, Pluskiewicz W, Gumprecht J. Associations between the VDR gene rs731236 (TaqI) polymorphism and bone mineral density in postmenopausal women from the RAC-OST-POL. Biomedicines. 2024; 12(4): 917, CrossRef.
Nugroho H, Mughni A, Putranto IK, Prasetya AT, Novitasari V. Combined sleeve gastrectomy and omentoplasty improves inflammation and insulin resistance in obese rats with type II diabetes mellitus: A randomized controlled trials. Indones Biomed J. 2024; 16(3): 277-84, CrossRef.
Al-Mashhadi ZK, Viggers R, Fuglsang-Nielsen R, Vestergaard P, Gregersen S, Starup-Linde J. The risk of major osteoporotic fractures with GLP-1 receptor agonists when compared to DPP-4 inhibitors: a Danish nationwide cohort study. Front Endocrinol. 2022: 13: 882998, CrossRef.
Al-Mashhadi Z, Viggers R, Fuglsang-Nielsen R, de Vries F, van den Bergh JP, Harsløf T, et al. Glucose-lowering drugs and fracture risk-A systematic review. Curr Osteoporos Rep. 2020; 18(6): 737-58, CrossRef.
Soysa NS, Alles N. Positive and negative regulators of osteoclast apoptosis. Bone Rep. 2019; 11: 100225, CrossRef.
Daniilopoulou I, Vlachou E, Lambrou GI, Ntikoudi A, Dokoutsidou E, Fasoi G, et al. The impact of GLP1 agonists on bone metabolism: A systematic review. Medicina. 2022; 58(2): 224, CrossRef.
Zhang L, He J, Sun X, Luo X, Zeng J, He W, et al. Relationship between glucagon-like peptide-1 receptor gene polymorphism and bone mineral density in postmenopausal women in Shanghai. Ann Palliat Med. 2020; 9(4): 1732-41, CrossRef.
Bao X, Liu C, Liu H, Wang Y, Xue P, Li Y. Association between polymorphisms of glucagon-like peptide-1 receptor gene and susceptibility to osteoporosis in Chinese postmenopausal women. J Orthop Surg Res. 2024; 19(1): 869, CrossRef.
Abdul-Maksoud RS, Elsayed WS, Rashad NM, Elsayed RS, Elshorbagy S, Hamed MG. GLP-1R polymorphism (rs1042044) and expression are associated with the risk of papillary thyroid cancer among the Egyptian population. Gene. 2022; 834: 146597, CrossRef.
Luo P, Fan Y, Xiong Y, Feng H, Yang Z, Zhang C, et al. Genetic variants of the GLP-1R gene affect the susceptibility and glucose metabolism of gestational diabetes mellitus: a two-center nested case-control study. Diabetol Metab Syndr. 2022; 14(1): 190, CrossRef.
Ammar KA, Altaee MF. Recurrent of TMPRSS2 genetic polymorphism and its role in Iraqi patients with prostate cancer. Iraqi J Agric Sci. 2022; 53(2): 272-7, CrossRef.
Iannone F, Angotti E, Lucia F, Martino L, Antico GC, Galato F, et al. The biological variation of serum 1, 25-dihydroxyvitamin D and parathyroid hormone, and plasma fibroblast growth factor 23 in healthy individuals. Clinica Chimica Acta. 2024; 557: 117863, CrossRef.
Pandey D, Basnet S, Pradhananga S, Shrestha S, Rijal B, Neupane A, et al. Prevalence and risk factors of osteoporosis among postmenopausal women visiting a district hospital of Nepal: An observational study. J Nepal Med Assoc. 2024; 62(279): 744-9, CrossRef.
LeBoff MS, Greenspan SL, Insogna KL, Lewiecki EM, Saag KG, Singer AJ, et al. The clinician's guide to prevention and treatment of osteoporosis. Osteoporos Int. 2022; 33(10): 2049-102, CrossRef.
National Osteoporosis Foundation. America's Bone Health : The State of Osteoporosis and Low Bone Mass in Our Nation. Washington D.C.: The Foundation; 2022.
Anam AK, Insogna K. Update on osteoporosis screening and management. Med Clin North Am. 2021; 105(6): 1117-34, CrossRef.
Hendrianingtyas M, Rachmawati B, Riwanto I, Mulyono B, Suhartono S, Winarni TI, et al. Parathyroid hormone-25 (OH) D and calcium-phosphorus ratio as osteopenia risk factors in women with central obesity. Indones Biomed J. 2022; 14(2): 148-55, CrossRef.
Mosca MJ, He Z, Selvamurugan N, Joseph J, Petrosky W, Le Henaff C, et al. PTH stimulation of Rankl transcription is regulated by SIK2 and 3 and mediated by CRTC2 and 3 through action of protein phosphatases 1, 2, 4, and 5. J Biol Chem. 2025; 301(8): 110434, CrossRef.
Sharma DK, Anderson PH, Morris HA, Clifton PM. Visceral fat is a negative determinant of bone health in obese postmenopausal women. Int J Environ Res Public Health. 2020; 17(11): 3996, CrossRef.
Yapici-Eser H, Appadurai V, Eren CY, Yazici D, Chen CY, Öngür D, et al. Association between GLP-1 receptor gene polymorphisms with reward learning, anhedonia and depression diagnosis. Acta neuropsychiatrica. 2020; 32(4): 218-25, CrossRef.
Sun Y, Liu Y, Dian Y, Zeng F, Deng G, Lei S. Association of glucagon-like peptide-1 receptor agonists with risk of cancers-evidence from a drug target Mendelian randomization and clinical trials. Int J Surg. 2024; 110(8): 4688-94, CrossRef.
Virolainen SJ, VonHandorf A, Viel KC, Weirauch MT, Kottyan LC. Gene-environment interactions and their impact on human health. Genes Immun. 2023; 24(1): 1-11, CrossRef.
Song J, Zhuang Y, Pan X, Chen Y, Xie F. Variants in PPARD-GLP1R are related to diabetic kidney disease in Chinese Han patients with type 2 diabetes mellitus. Heliyon. 2024; 10(15): e35289, CrossRef.
Gomaa AA, Zeid AM, Nagy IM. The role of GLP1R gene polymorphism in diabetic nephropathy in patients with type 2 diabetes. Gene Reports. 2025; 39: 102205, CrossRef.
Demie DT, Döring TF, Finckh MR, van der Werf W, Enjalbert J, Seidel SJ. Mixture × genotype effects in cereal/legume intercropping. Front Plant Sci. 2022; 13: 846720, CrossRef.
Alemu SW, Bijma P, Calus MP, Liu H, Fernando RL, Dekkers JC. Comparison of linkage disequilibrium estimated from genotypes versus haplotypes for crossbred populations. Genet Sel Evol. 2022; 54(1): 12, CrossRef.
Forero DA, Chand V. Methods in molecular biology and genetics: Looking to the future. BMC Res Notes. 2023; 16(1): 26, CrossRef.
DOI: https://doi.org/10.18585/inabj.v17i5.3768
Copyright (c) 2025 The Prodia Education and Research Institute
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Indexed by:
The Prodia Education and Research Institute
